͵͵

Journal News

Researchers get to the bottom of noninvasive gut tests

Mucus contains vital data to help address diseases such as inflammatory bowel disease and colon cancer
David Bidwell
By David Bidwell
March 3, 2024

New research from the University of British Columbia Okanagan, recently in the Journal of Biological Chemistry could make monitoring gut health easier and less painful by tapping into a common — yet often overlooked — source of information: the mucus in our digestive system that eventually becomes part of fecal matter.

Correct, what’s in our poop.

close-up of man holding his abdomen.
Liubomyr Vorona
New research from UBC Okanagan showed that noninvasive techniques can return vital gut health data from the mucus in our fecal matter.

Biology researcher Kirk Bergstrom and master’s student Noah Fancy found a noninvasive technique to study MUC2, a critical gut protein, from what we leave behind in the bathroom.

“MUC2 is like the silent star in our guts. It’s constantly working to protect us, and its proper functioning is crucial for our overall health,” Bergstrom said. “It was originally thought that you could only access this important molecule from biopsies or tissue removed via surgery — highly invasive and painful procedures.

“However, our study shows mucus is actually a part of our stool, meaning we can get at it painlessly and at levels we could not before. Anytime we can do analysis noninvasively, it’s a win.”

Clues to health can be found in unexpected places, and Bergstrom’s team found a way to study important gut health markers from fecal-adherent mucus — a term that, in simpler words, refers to the mucus attached to our stool. This mucus, typically ignored and flushed away, contains a trove of information about gut health.

MUC2, a glycoprotein with many sugar chains attached, forms a protective barrier in our intestines in the form of mucus, safeguarding our gut from harmful microbes and toxins and playing a crucial role in digestive health.

Understanding MUC2 better could lead to significant advancements in managing and preventing gut-related diseases, impacting the day-to-day well-being of millions.

“We can use these new methods to visualize mucus–microbiota interactions and how they go wrong in various diseases, like inflammatory bowel diseases and colon cancer,” Bergstrom noted.  “The sugars on the mucins also carry lots of information on the health status of the colon.”

Fancy led the work, which was the result of a strong collaborative effort between the Bergstrom Lab and the chemistry lab of Wesley Zandberg and the biology labs of Sepideh Pakpour, Deanna Gibson and Sanjoy Ghosh, all at UBC Okanagan.

This article was originally published in the . You can read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
David Bidwell
David Bidwell

David Bidwell is a writer and content strategist, University Relations, University of British Columbia Okanagan.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.